Daratumumab after allogeneic hematopoietic cell transplantation for multiple myeloma is safe and synergies with pre-existing chronic graft versus host disease. A retrospective study from the CMWP EBMT.

Vincent, Laure; Gras, Luuk; Ceballos, Patrice; Finke, Jürgen; Passweg, Jakob; Harel, Stéphanie; Rosinol, Laura; Minnema, Monique; Teipel, Raphael; van Doesum, Jaap; Hänel, Mathias; Lenain, Pascal; Botella-Garcia, Carmen; Koenecke, Christian; Ducastelle, Sophie; Sanz, Jaime; Schroyens, Wilfried; Zuckerman, Tsila; Monaco, Federico; Koster, Linda; de Wreede, Liesbeth; Hayden, Patrick J; Schönland, Stefan; Yakoub-Agha, Ibrahim; Beksac, Meral

Vincent, Laure; Gras, Luuk; Ceballos, Patrice; Finke, Jürgen; Passweg, Jakob; Harel, Stéphanie; Rosinol, Laura; Minnema, Monique; Teipel, Raphael; van Doesum, Jaap; Hänel, Mathias; Lenain, Pascal; Botella-Garcia, Carmen; Koenecke, Christian; Ducastelle, Sophie; Sanz, Jaime; Schroyens, Wilfried; Zuckerman, Tsila; Monaco, Federico; Koster, Linda; de Wreede, Liesbeth; Hayden, Patrick J; Schönland, Stefan; Yakoub-Agha, Ibrahim; Beksac, Meral.

Afiliação

Vincent L; CHU de Montpellier, Hôpital St Eloi, Montpellier, France. l-vincent@chu-montpellier.fr.
Gras L; EBMT Statistical Unit, Leiden, The Netherlands.
Ceballos P; CHU de Montpellier, Hôpital St Eloi, Montpellier, France.
Finke J; University of Freiburg, Freiburg, Germany.
Passweg J; University Hospital of Basel, Basel, Switzerland.
Harel S; Hôpital St Louis, Paris, France.
Rosinol L; Barcelona Hospital Clinic, Barcelona, Spain.
Minnema M; University Medical Center Utrecht, Utrecht, Netherlands.
Teipel R; University Hospital Carl Gustav Carus, Dresden, Germany.
van Doesum J; University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Hänel M; Klinikum Chemnitz, Chemnitz, Germany.
Lenain P; Centre Henri Becquerel, Rouen, France.
Botella-Garcia C; Hôpital Haut-Levèque, Pessac, France.
Koenecke C; Hannover Medical School, Hannover, Germany.
Ducastelle S; CHU Lyon Sud, Pierre-Benite, France.
Sanz J; Hospital Universitari I politècnic La Fe, Valencia, Spain.
Schroyens W; Antwerp University Hospital (UZA), Antwerp-Edegem, Belgium.
Zuckerman T; Rambam Medical Center, Haifa, Israel.
Monaco F; A.O. SS. Antonio e Biagio e Cesare Arrigo, Alessandria, Italy.
Koster L; EBMT Data Office, Leiden, UK.
de Wreede L; Leiden University Medical Center, Leiden, The Netherlands.
Hayden PJ; St. James Hospital, Trinity College Dublin, Dublin, Ireland.
Schönland S; University of Heidelberg, Heidelberg, Germany.
Yakoub-Agha I; CHU de Lille, Université de Lille, INSERM U1286, Infinite, Lille, France.
Beksac M; Ankara University Faculty of Medicine, Ankara, Turkey.

Bone Marrow Transplant ; 57(3): 499-501, 2022 03.

Article em En | MEDLINE | ID: mdl-35013536

Assuntos

Doença Enxerto-Hospedeiro; Transplante de Células-Tronco Hematopoéticas; Mieloma Múltiplo; Anticorpos Monoclonais; Humanos; Mieloma Múltiplo/terapia; Estudos Retrospectivos; Condicionamento Pré-Transplante

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Doença Enxerto-Hospedeiro / Mieloma Múltiplo Tipo de estudo: Observational_studies Limite: Humans Idioma: En Revista: Bone Marrow Transplant Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google